These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19778340)

  • 1. Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization.
    Tournamille C; Meunier-Costes N; Costes B; Martret J; Barrault A; Gauthier P; Galactéros F; Nzouékou R; Bierling P; Noizat-Pirenne F
    Transfusion; 2010 Jan; 50(1):13-9. PubMed ID: 19778340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red blood cell alloimmunization in sickle cell disease patients in Uganda.
    Natukunda B; Schonewille H; Ndugwa C; Brand A
    Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell alloimmunization in sickle cell disease: the influence of racial and antigenic pattern differences between donors and recipients in Brazil.
    Moreira Júnior G; Bordin JO; Kuroda A; Kerbauy J
    Am J Hematol; 1996 Jul; 52(3):197-200. PubMed ID: 8756087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of partial DIIIa and DAR alleles found in sickle cell disease patients suggests increased risk of alloimmunization to RhD.
    Castilho L; Rios M; Rodrigues A; Pellegrino J; Saad ST; Costa FF
    Transfus Med; 2005 Feb; 15(1):49-55. PubMed ID: 15713129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
    O'Suoji C; Liem RI; Mack AK; Kingsberry P; Ramsey G; Thompson AA
    Pediatr Blood Cancer; 2013 Sep; 60(9):1487-91. PubMed ID: 23508932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Cox JV; Steane E; Cunningham G; Frenkel EP
    Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-HrB and anti-hrb revisited.
    Pham BN; Peyrard T; Tourret S; Beolet M; Many H; Juszczak G; Roussel M; Kappler-Gratias S; Rouger P; Le Pennec PY
    Transfusion; 2009 Nov; 49(11):2400-5. PubMed ID: 19624490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloanti-c (RH4) revealing that the (C)ce s haplotype encodes a partial c antigen.
    Pham BN; Peyrard T; Juszczak G; Auxerre C; Godin S; Bonin P; Rouger P; Le Pennec PY
    Transfusion; 2009 Jul; 49(7):1329-34. PubMed ID: 19320865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red cell alloantibodies in patients with haemoglobinopathies.
    Hmida S; Mojaat N; Maamar M; Bejaoui M; Mediouni M; Boukef K
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):363-6. PubMed ID: 7892131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease.
    Ribeiro KR; Guarnieri MH; da Costa DC; Costa FF; Pellegrino J; Castilho L
    Vox Sang; 2009 Aug; 97(2):147-52. PubMed ID: 19392786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion.
    Ameen R; Al Shemmari S; Al-Bashir A
    Transfusion; 2009 Aug; 49(8):1649-54. PubMed ID: 19453992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
    Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
    Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?
    Schonewille H; van de Watering LM; Brand A
    Transfusion; 2006 Apr; 46(4):630-5. PubMed ID: 16584440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloanti-c/ce in a c+ceAR/Ce patient suggests that the rare RHCE ceAR allele (ceAR) encodes a partial c antigen.
    Peyrard T; Pham BN; Poupel S; Martin-Blanc S; Auxerre C; Kappler-Gratias S; Bonin P; Rouger P; Le Pennec PY
    Transfusion; 2009 Nov; 49(11):2406-11. PubMed ID: 19624489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.
    Vichinsky EP; Earles A; Johnson RA; Hoag MS; Williams A; Lubin B
    N Engl J Med; 1990 Jun; 322(23):1617-21. PubMed ID: 2342522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of anti-D in D- recipients transfused with D+ red blood cells.
    Yazer MH; Triulzi DJ
    Transfusion; 2007 Dec; 47(12):2197-201. PubMed ID: 17714422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed hemolytic transfusion reaction due to anti-Go(a), an antibody against the low-prevalence Gonzales antigen.
    Larson PJ; Lukas MB; Friedman DF; Manno CS
    Am J Hematol; 1996 Dec; 53(4):248-50. PubMed ID: 8948664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of 206 transfused sickle cell disease patients: immunization, transfusion safety and red blood cell supply].
    Meunier N; Rodet M; Bonin P; Chadebech P; Chami B; Lee K; Habibi A; Bachir D; Galactéros F; Bierling P; Noizat-Pirenne F
    Transfus Clin Biol; 2008 Dec; 15(6):377-82. PubMed ID: 19026581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary anti-D immunization by Del red blood cells.
    Yasuda H; Ohto H; Sakuma S; Ishikawa Y
    Transfusion; 2005 Oct; 45(10):1581-4. PubMed ID: 16181208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody development in pediatric sickle cell patients undergoing erythrocytapheresis.
    Godfrey GJ; Lockwood W; Kong M; Bertolone S; Raj A
    Pediatr Blood Cancer; 2010 Dec; 55(6):1134-7. PubMed ID: 20979172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.